JPS6134402B2 - - Google Patents
Info
- Publication number
- JPS6134402B2 JPS6134402B2 JP53118096A JP11809678A JPS6134402B2 JP S6134402 B2 JPS6134402 B2 JP S6134402B2 JP 53118096 A JP53118096 A JP 53118096A JP 11809678 A JP11809678 A JP 11809678A JP S6134402 B2 JPS6134402 B2 JP S6134402B2
- Authority
- JP
- Japan
- Prior art keywords
- resin
- fat
- ion exchange
- suspension
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000002468 fat body Anatomy 0.000 claims description 24
- 239000000725 suspension Substances 0.000 claims description 21
- 239000011347 resin Substances 0.000 claims description 18
- 229920005989 resin Polymers 0.000 claims description 18
- 150000002632 lipids Chemical class 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 8
- 239000003456 ion exchange resin Substances 0.000 claims description 8
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 8
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003463 adsorbent Substances 0.000 claims description 5
- 125000000129 anionic group Chemical group 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 150000003839 salts Chemical group 0.000 claims 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 238000005199 ultracentrifugation Methods 0.000 description 3
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 2
- 229940093541 dicetylphosphate Drugs 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 2
- 239000008344 egg yolk phospholipid Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000005170 neoplastic cell Anatomy 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2814777 | 1977-09-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5459314A JPS5459314A (en) | 1979-05-12 |
| JPS6134402B2 true JPS6134402B2 (da) | 1986-08-07 |
Family
ID=11223032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11809678A Granted JPS5459314A (en) | 1977-09-30 | 1978-09-27 | Minute fat globule suspension |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5459314A (da) |
| AT (1) | AT368879B (da) |
| AU (1) | AU528260B2 (da) |
| BE (1) | BE870882A (da) |
| CA (1) | CA1116518A (da) |
| CH (1) | CH642540A5 (da) |
| DE (1) | DE2842608C2 (da) |
| DK (1) | DK154048C (da) |
| FR (1) | FR2404454A1 (da) |
| GB (1) | GB2004745B (da) |
| NL (1) | NL7809709A (da) |
| SE (1) | SE433038B (da) |
| ZA (1) | ZA785510B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1110989B (it) * | 1979-01-19 | 1986-01-13 | Erba Farmitalia | Forme farmaceutiche costitutite da liposomi e procedimenti relativi |
| JPS5775916A (en) * | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Coenzyme q pharmaceutical and its preparation |
| JPS5782310A (en) * | 1980-11-11 | 1982-05-22 | Tanabe Seiyaku Co Ltd | Production of liposome preparation |
| CA1270198C (en) * | 1984-08-08 | 1990-06-12 | Marcel B Bally | ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES |
| US4619795A (en) * | 1984-12-24 | 1986-10-28 | Technicon Instruments Corp. | Method for preparing lipid vesicles |
| DE4038075C1 (en) * | 1990-11-29 | 1992-03-19 | B. Braun Melsungen Ag, 3508 Melsungen, De | Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium |
| DE10137515A1 (de) * | 2001-07-26 | 2003-02-13 | Diagnostikforschung Inst | Verfahren zur Herstellung pharmazeutischer Zubereitungen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2249552A1 (de) * | 1971-10-12 | 1973-05-30 | Inchema S A | Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen |
| GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
-
1978
- 1978-09-25 NL NL7809709A patent/NL7809709A/xx not_active Application Discontinuation
- 1978-09-25 AU AU40174/78A patent/AU528260B2/en not_active Expired
- 1978-09-25 CA CA000312035A patent/CA1116518A/en not_active Expired
- 1978-09-26 FR FR7827488A patent/FR2404454A1/fr active Granted
- 1978-09-26 SE SE7810109A patent/SE433038B/sv not_active IP Right Cessation
- 1978-09-26 AT AT0693178A patent/AT368879B/de active
- 1978-09-26 DK DK425478A patent/DK154048C/da not_active IP Right Cessation
- 1978-09-27 JP JP11809678A patent/JPS5459314A/ja active Granted
- 1978-09-28 ZA ZA00785510A patent/ZA785510B/xx unknown
- 1978-09-28 GB GB7838495A patent/GB2004745B/en not_active Expired
- 1978-09-29 BE BE190800A patent/BE870882A/xx not_active IP Right Cessation
- 1978-09-29 CH CH1016078A patent/CH642540A5/de not_active IP Right Cessation
- 1978-09-29 DE DE2842608A patent/DE2842608C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2404454B1 (da) | 1980-06-20 |
| DE2842608C2 (de) | 1986-02-06 |
| NL7809709A (nl) | 1979-04-03 |
| DK154048B (da) | 1988-10-10 |
| CH642540A5 (de) | 1984-04-30 |
| FR2404454A1 (fr) | 1979-04-27 |
| AU528260B2 (en) | 1983-04-21 |
| JPS5459314A (en) | 1979-05-12 |
| DE2842608A1 (de) | 1979-04-12 |
| DK154048C (da) | 1989-03-13 |
| SE7810109L (sv) | 1979-03-31 |
| ATA693178A (de) | 1982-04-15 |
| DK425478A (da) | 1979-03-31 |
| GB2004745A (en) | 1979-04-11 |
| AU4017478A (en) | 1980-04-03 |
| CA1116518A (en) | 1982-01-19 |
| ZA785510B (en) | 1979-09-26 |
| AT368879B (de) | 1982-11-25 |
| BE870882A (fr) | 1979-03-29 |
| SE433038B (sv) | 1984-05-07 |
| GB2004745B (en) | 1982-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4460577A (en) | Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same | |
| CA1143656A (en) | Liposome including active substance | |
| EP0036676B2 (en) | Method of making uniformly sized liposomes and liposomes so made | |
| KR100387561B1 (ko) | 활성제제의조절방출을위한다중소포성리포솜의제법 | |
| EP1131053B1 (de) | Nanokapseln und verfahren zur herstellung dieser | |
| EP0498471A2 (en) | Liposomes comprising a guanidino aminoglycoside | |
| JPS6150912A (ja) | リポソ−ム製剤の製造法 | |
| JP2517094B2 (ja) | リン脂質組成物 | |
| JPS6339810A (ja) | リポソ−ムの製造法 | |
| CA1148470A (en) | Pharmaceutical compositions consisting or consisting essentially of liposomes and processes for making same | |
| JPH04288019A (ja) | ギンクゴ・ビロバ葉の抽出物および用途 | |
| TWI455731B (zh) | 醫藥應用的乾燥重建之囊胞結構 | |
| CH648494A5 (de) | Verfahren zur herstellung von einen wirkstoff enthaltenden mikrokapseln. | |
| JPS6111931B2 (da) | ||
| JPS6134402B2 (da) | ||
| JPH0437731B2 (da) | ||
| DD262808A1 (de) | Vesikulaere fuellkoerper fuer die chromatographie aus denaturierten mikroorganismen und verfahren zur herstellung | |
| GB2144332A (en) | Pharmaceutical preparations containing fructose-1,6-diphosphate | |
| JPH0624999A (ja) | リポソーム製剤 | |
| JPH0482839A (ja) | 蛋白質類・脂質小体複合体 | |
| AU641532B2 (en) | Liposome preparation and antibiotic | |
| JPH03167194A (ja) | レシチンの精製方法 |